Diversified Healthcare Trust Common Shares of Beneficial Interest financials
$7.96−2.09%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $365.4M | $366.5M | $379.6M | $388.7M | $382.7M | $386.9M | $379.6M | $373.6M | $371.4M | $370.8M | $361.5M | $356.5M |
| Gross profit | $365.4M | $366.5M | $379.6M | $388.7M | $382.7M | $386.9M | $379.6M | $373.6M | $371.4M | $370.8M | $361.5M | $356.5M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | -$518.0K | -$4.7M | -$14.1M | -$109.2M | -$38.4M | -$43.3M | -$41.1M | -$42.3M | -$15.7M | -$26.8M | -$42.4M | -$17.3M |
| Net income | -$37.4M | -$43.4M | -$21.2M | -$164.0M | -$91.6M | -$9.0M | -$87.4M | -$98.7M | -$97.9M | -$86.3M | -$102.6M | -$65.8M |
| Net margin | −10.2% | −11.8% | −5.6% | −42.2% | −23.9% | −2.3% | −23.0% | −26.4% | −26.3% | −23.3% | −28.4% | −18.5% |
| Diluted EPS | $-0.16 | $-0.18 | $-0.09 | $-0.68 | $-0.38 | $-0.04 | $-0.36 | $-0.41 | $-0.41 | $-0.36 | $-0.43 | $-0.28 |
| EBITDA | $65.1M | $61.9M | $59.9M | $50.6M | $59.0M | $63.5M | $65.6M | $50.1M | $61.1M | $55.5M | -$31.5M | $51.4M |
| Operating cash flow | $38.3M | $8.4M | -$20.1M | -$49.3M | $51.5M | -$1.8M | $18.2M | $21.1M | $44.3M | $28.6M | -$5.4M | -$10.1M |
| Free cash flow | $14.1M | -$26.7M | -$52.5M | -$89.8M | $17.4M | -$41.4M | -$48.5M | -$26.1M | $3.3M | -$18.1M | -$72.0M | -$70.6M |
| Diluted shares | 240.7M | 240.7M | 240.7M | 240.4M | 240.1M | 240.0M | 240.0M | 239.7M | 239.3M | 239.2M | 239.2M | 238.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $116.8M | $121.8M | $105.4M | $201.4M | $141.8M | $302.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.40B | $2.40B | $2.40B | $2.74B | $2.66B | $2.80B |
| Total assets | $4.24B | $4.27B | $4.36B | $4.68B | $4.76B | $5.00B |
| Total liabilities | $2.66B | $2.65B | $2.70B | $3.00B | $2.90B | $3.05B |
| Shareholders' equity | $1.58B | $1.62B | $1.67B | $1.69B | $1.85B | $1.95B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology